Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers

被引：16

作者：

Russano, Marco ^{[1
]}

La Cava, Giulia ^{[1
]}

Cortellini, Alessio ^{[1
]}

Citarella, Fabrizio ^{[1
]}

Galletti, Alessandro ^{[2
]}

Di Fazio, Giuseppina Rita ^{[1
]}

Santo, Valentina ^{[1
]}

Brunetti, Leonardo ^{[1
]}

Vendittelli, Alessia ^{[1
]}

Fioroni, Iacopo ^{[1
]}

Pantano, Francesco ^{[1
]}

Tonini, Giuseppe ^{[1
]}

Vincenzi, Bruno ^{[1
]}

机构：

[1] Campus Biomed Univ Rome, Dept Med Oncol, Via Alvaro Portillo 21, I-00128 Rome, Italy

[2] San Camillo Forlanini Hosp, Div Med Oncol, I-00152 Rome, Italy

来源：

CURRENT ONCOLOGY | 2023年 / 30卷 / 02期

关键词：

immunotherapy; non-small cell lung cancer; immune checkpoint inhibitors; PD-1; PD-L1; antibodies; combination strategies; biomarkers; tissue biomarkers; liquid biopsy; IMMUNE CHECKPOINT INHIBITORS; PD-L1; EXPRESSION; NSCLC PATIENTS; OPEN-LABEL; CHEMOTHERAPY CHEMO; 1ST-LINE NIVOLUMAB; ADVERSE EVENTS; CHECKMATE; 9LA; PATIENTS PTS; PHASE-III;

D O I：

10.3390/curroncol30020181

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immunotherapy has revolutionized the treatment paradigm of non-small cell lung cancer and improved patients' prognosis. Immune checkpoint inhibitors have quickly become standard frontline treatment for metastatic non-oncogene addicted disease, either as a single agent or in combination strategies. However, only a few patients have long-term benefits, and most of them do not respond or develop progressive disease during treatment. Thus, the identification of reliable predictive and prognostic biomarkers remains crucial for patient selection and guiding therapeutic choices. In this review, we provide an overview of the current strategies, highlighting the main clinical challenges and novel potential biomarkers.

引用

页码：2366 / 2387

页数：22

共 178 条

[1] Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer [J].

Aggarwal, Charu ;

Thompson, Jeffrey C. ;

Chien, Austin L. ;

Quinn, Katie J. ;

Hwang, Wei-Ting ;

Black, Taylor A. ;

Yee, Stephanie S. ;

Christensen, Theresa E. ;

LaRiviere, Michael J. ;

Silva, Benjamin A. ;

Banks, Kimberly C. ;

Nagy, Rebecca J. ;

Helman, Elena ;

Berman, Abigail T. ;

Ciunci, Christine A. ;

Singh, Aditi P. ;

Wasser, Jeffrey S. ;

Bauml, Joshua M. ;

Langer, Corey J. ;

Cohen, Roger B. ;

Carpenter, Erica L. .

CLINICAL CANCER RESEARCH, 2020, 26 (10) :2354-2361

[2] MEDI5752 or pembrolizumab (P) plus carboplatin/pemetrexed (CP) in treatment-naive (1L) non-small cell lung cancer (NSCLC): A phase Ib/II trial [J].

Ahn, M-J. ;

Kim, S-W. ;

Carcereny Costa, E. ;

Rodriguez, L. M. ;

Oliveira, J. ;

Insa Molla, M. A. ;

Majem, M. ;

Costa, L. ;

Su, W-C. ;

Lee, K. H. ;

Yang, J. C-H. ;

Spigel, D. R. ;

Cho, E. K. ;

D'Arcangelo, M. ;

Garcia Campelo, M. R. ;

Delmonte, A. ;

Mitchell, P. ;

Achour, I. ;

Subramaniam, D. ;

Felip, E. .

ANNALS OF ONCOLOGY, 2022, 33 (07) :S1423-S1423

[3] Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries [J].

Allemani, Claudia ;

Matsuda, Tomohiro ;

Di Carlo, Veronica ;

Harewood, Rhea ;

Matz, Melissa ;

Niksic, Maja ;

Bonaventure, Audrey ;

Valkov, Mikhail ;

Johnson, Christopher J. ;

Esteve, Jacques ;

Ogunbiyi, Olufemi J. ;

Azevedo e Silva, Gulnar ;

Chen, Wan-Qing ;

Eser, Sultan ;

Engholm, Gerda ;

Stiller, Charles A. ;

Monnereau, Alain ;

Woods, Ryan R. ;

Visser, Otto ;

Lim, Gek Hsiang ;

Aitken, Joanne ;

Weir, Hannah K. ;

Coleman, Michel P. .

LANCET, 2018, 391 (10125) :1023-1075

[4] Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer [J].

Andre, T. ;

Shiu, K-K ;

Kim, T. W. ;

Jensen, B., V ;

Jensen, L. H. ;

Punt, C. ;

Smith, D. ;

Garcia-Carbonero, R. ;

Benavides, M. ;

Gibbs, P. ;

de la Fouchardiere, C. ;

Rivera, F. ;

Elez, E. ;

Bendell, J. ;

Le, D. T. ;

Yoshino, T. ;

Van Cutsem, E. ;

Yang, P. ;

Farooqui, M. Z. H. ;

Marinello, P. ;

Diaz, L. A., Jr. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) :2207-2218

[5] Immune checkpoint inhibitors at any treatment line in advanced NSCLC: Real-world overall survival in a large Italian cohort [J].

Andreano, Anita ;

Bergamaschi, Walter ;

Russo, Antonio Giampiero .

LUNG CANCER, 2021, 159 :145-152

[6] Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].

Antonia, S. J. ;

Villegas, A. ;

Daniel, D. ;

Vicente, D. ;

Murakami, S. ;

Hui, R. ;

Kurata, T. ;

Chiappori, A. ;

Lee, K. H. ;

de Wit, M. ;

Cho, B. C. ;

Bourhaba, M. ;

Quantin, X. ;

Tokito, T. ;

Mekhail, T. ;

Planchard, D. ;

Kim, Y. -C. ;

Karapetis, C. S. ;

Hiret, S. ;

Ostoros, G. ;

Kubota, K. ;

Gray, J. E. ;

Paz-Ares, L. ;

Carpeno, J. de Castro ;

Faivre-Finn, C. ;

Reck, M. ;

Vansteenkiste, J. ;

Spigel, D. R. ;

Wadsworth, C. ;

Melillo, G. ;

Taboada, M. ;

Dennis, P. A. ;

Ozguroglu, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350

[7] Hyperprogressive Disease: Main Features and Key Controversies [J].

Arasanz, Hugo ;

Zuazo, Miren ;

Bocanegra, Ana ;

Chocarro, Luisa ;

Blanco, Ester ;

Martinez, Maite ;

Morilla, Idoia ;

Fernandez, Gonzalo ;

Teijeira, Lucia ;

Morente, Pilar ;

Echaide, Miriam ;

Castro, Natalia ;

Fernandez, Leticia ;

Garnica, Maider ;

Ramos, Pablo ;

Escors, David ;

Kochan, Grazyna ;

Vera, Ruth .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (07)

[8] Strategies to overcome resistance to immune checkpoint blockade in lung cancer [J].

Attili, Ilaria ;

Tarantino, Paolo ;

Passaro, Antonio ;

Stati, Valeria ;

Curigliano, Giuseppe ;

de Marinis, Filippo .

LUNG CANCER, 2021, 154 :151-160

[9] Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy-The Role of Liquid Biopsy in Unraveling the Puzzle [J].

Augustus, Elien ;

Zwaenepoel, Karen ;

Siozopoulou, Vasiliki ;

Raskin, Jo ;

Jordaens, Stephanie ;

Baggerman, Geert ;

Sorber, Laure ;

Roeyen, Geert ;

Peeters, Marc ;

Pauwels, Patrick .

CANCERS, 2021, 13 (07)

[10] Mechanisms of Cancer Resistance to Immunotherapy [J].

Bai, Rilan ;

Chen, Naifei ;

Li, Lingyu ;

Du, Nawen ;

Bai, Ling ;

Lv, Zheng ;

Tian, Huimin ;

Cui, Jiuwei .

FRONTIERS IN ONCOLOGY, 2020, 10

← 1 2 3 4 5 6 7 8 9 10 →